Open AccessBystander suppression of murine collagen‐induced arthritis by long‐term nasal administration of a self type II collagen peptide
Author(s) -
Bayrak Ş.,
Mitchison N. A.
Publication year - 1998
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1046/j.1365-2249.1998.00638.x
Subject(s) - collagen induced arthritis , bystander effect , immunology , arthritis , peptide , inflammation , type ii collagen , chemistry , nasal administration , medicine , biochemistry
Oral and more recently nasal tolerance have attracted attention as potential treatments of autoimmune disease. Arthritis induced by bovine type II collagen (CII) is a widely used animal model of rheumatoid arthritis, which is here used to investigate the efficacy of nasal treatment by a short peptide. The peptide spans residues 707–721 (designated p707), an epitope of mouse CII that is most strongly recognized after immunization of mice with this self‐protein. The treatment was partially effective, but almost only when the peptide was administered in large doses over a prolonged period. Mice immunized with bovine CII respond mainly to other peptides, located in the CB11 fragment around amino acid residues 256–270. The tolerance effect therefore results from intramolecular suppression, between epitopes located in different parts of this large protein.